Image

Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

Exploring vancomycin use in children with suspected sepsis.

Recruiting
All
Phase N/A

Study Summary: This study aims to reduce the use of an antibiotic called vancomycin in children with suspected sepsis, a serious infection. Vancomycin is often used in hospitals for children, but its overuse can cause kidney problems. The study will take place in five Pediatric Intensive Care Units (PICUs) and will involve both doctors and patients in these units. The intervention includes a new guideline to help doctors decide when to use vancomycin, education for doctors, and feedback on how much vancomycin is being used.

Key Points:

  • Duration: The study will last about 24 months.
  • Participants: Patients in participating PICUs and clinicians working there.
  • Benefits: The goal is to prevent kidney harm by reducing unnecessary vancomycin use.

The study will use data from Electronic Health Records (EHR) to track vancomycin use before and after the intervention. There are no specific exclusions for patients, but clinicians must be 18 or older and employed at a participating site. Volunteers and those with limited English may not participate.

Study details
    Sepsis
    Sepsis Mrsa
    Sepsis Bacteremia
    Antimicrobial - Induced Nephropathy
    Sepsis
    Severe
    Septic Shock
    Septic Syndrome

NCT05975671

Children's Hospital of Philadelphia

13 December 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.